Active Ingredients and Mechanisms of Change in Motivational Interviewing for Medication Adherence. A Mixed Methods Study of Patient-Therapist Interaction in Patients With Schizophrenia

BackgroundTrials studying Motivational Interviewing (MI) to improve medication adherence in patients with schizophrenia showed mixed results. Moreover, it is unknown which active MI-ingredients are associated with mechanisms of change in patients with schizophrenia. To enhance the effect of MI for p...

Full description

Bibliographic Details
Main Authors: Jos Dobber, Corine Latour, Berno van Meijel, Gerben ter Riet, Emile Barkhof, Ron Peters, Wilma Scholte op Reimer, Lieuwe de Haan
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-03-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2020.00078/full
id doaj-8b5a51b0aa174b2a8830b8d80e814188
record_format Article
spelling doaj-8b5a51b0aa174b2a8830b8d80e8141882020-11-25T02:07:56ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402020-03-011110.3389/fpsyt.2020.00078496798Active Ingredients and Mechanisms of Change in Motivational Interviewing for Medication Adherence. A Mixed Methods Study of Patient-Therapist Interaction in Patients With SchizophreniaJos Dobber0Corine Latour1Berno van Meijel2Berno van Meijel3Berno van Meijel4Gerben ter Riet5Emile Barkhof6Ron Peters7Wilma Scholte op Reimer8Wilma Scholte op Reimer9Lieuwe de Haan10ACHIEVE Centre of Applied Research, Faculty of Health, Amsterdam University of Applied Sciences, Amsterdam, NetherlandsACHIEVE Centre of Applied Research, Faculty of Health, Amsterdam University of Applied Sciences, Amsterdam, NetherlandsResearch Group Mental Health Nursing, Inholland University of Applied Sciences, Amsterdam, NetherlandsDepartment of Psychiatry, Amsterdam UMC (VUmc), Amsterdam Public Health Research Institute, Amsterdam, NetherlandsParnassia Academy, Parnassia Psychiatric Institute, The Hague, NetherlandsDepartment of General Practice, Amsterdam UMC, University of Amsterdam, Amsterdam, NetherlandsGGZ Rivierduinen, Leiden, NetherlandsDepartment of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, NetherlandsACHIEVE Centre of Applied Research, Faculty of Health, Amsterdam University of Applied Sciences, Amsterdam, NetherlandsDepartment of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, NetherlandsDepartment of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam, NetherlandsBackgroundTrials studying Motivational Interviewing (MI) to improve medication adherence in patients with schizophrenia showed mixed results. Moreover, it is unknown which active MI-ingredients are associated with mechanisms of change in patients with schizophrenia. To enhance the effect of MI for patients with schizophrenia, we studied MI's active ingredients and its working mechanisms.MethodsFirst, based on MI literature, we developed a model of potential active ingredients and mechanisms of change of MI in patients with schizophrenia. We used this model in a qualitative multiple case study to analyze the application of the active ingredients and the occurrence of mechanisms of change. We studied the cases of fourteen patients with schizophrenia who participated in a study on the effect of MI on medication adherence. Second, we used the Generalized Sequential Querier (GSEQ 5.1) to perform a sequential analysis of the MI-conversations aiming to assess the transitional probabilities between therapist use of MI-techniques and subsequent patient reactions in terms of change talk and sustain talk.ResultsWe found the therapist factor “a trusting relationship and empathy” important to enable sufficient depth in the conversation to allow for the opportunity of triggering mechanisms of change. The most important conversational techniques we observed that shape the hypothesized active ingredients are reflections and questions addressing medication adherent behavior or intentions, which approximately 70% of the time was followed by “patient change talk”. Surprisingly, sequential MI-consistent therapist behavior like “affirmation” and “emphasizing control” was only about 6% of the time followed by patient change talk. If the active ingredients were embedded in more comprehensive MI-strategies they had more impact on the mechanisms of change.ConclusionsMechanisms of change mostly occurred after an interaction of active ingredients contributed by both therapist and patient. Our model of active ingredients and mechanisms of change enabled us to see “MI at work” in the MI-sessions under study, and this model may help practitioners to shape their MI-strategies to a potentially more effective MI.https://www.frontiersin.org/article/10.3389/fpsyt.2020.00078/fullmotivational interviewingschizophreniamedication adherenceactive ingredientsmechanisms of change
collection DOAJ
language English
format Article
sources DOAJ
author Jos Dobber
Corine Latour
Berno van Meijel
Berno van Meijel
Berno van Meijel
Gerben ter Riet
Emile Barkhof
Ron Peters
Wilma Scholte op Reimer
Wilma Scholte op Reimer
Lieuwe de Haan
spellingShingle Jos Dobber
Corine Latour
Berno van Meijel
Berno van Meijel
Berno van Meijel
Gerben ter Riet
Emile Barkhof
Ron Peters
Wilma Scholte op Reimer
Wilma Scholte op Reimer
Lieuwe de Haan
Active Ingredients and Mechanisms of Change in Motivational Interviewing for Medication Adherence. A Mixed Methods Study of Patient-Therapist Interaction in Patients With Schizophrenia
Frontiers in Psychiatry
motivational interviewing
schizophrenia
medication adherence
active ingredients
mechanisms of change
author_facet Jos Dobber
Corine Latour
Berno van Meijel
Berno van Meijel
Berno van Meijel
Gerben ter Riet
Emile Barkhof
Ron Peters
Wilma Scholte op Reimer
Wilma Scholte op Reimer
Lieuwe de Haan
author_sort Jos Dobber
title Active Ingredients and Mechanisms of Change in Motivational Interviewing for Medication Adherence. A Mixed Methods Study of Patient-Therapist Interaction in Patients With Schizophrenia
title_short Active Ingredients and Mechanisms of Change in Motivational Interviewing for Medication Adherence. A Mixed Methods Study of Patient-Therapist Interaction in Patients With Schizophrenia
title_full Active Ingredients and Mechanisms of Change in Motivational Interviewing for Medication Adherence. A Mixed Methods Study of Patient-Therapist Interaction in Patients With Schizophrenia
title_fullStr Active Ingredients and Mechanisms of Change in Motivational Interviewing for Medication Adherence. A Mixed Methods Study of Patient-Therapist Interaction in Patients With Schizophrenia
title_full_unstemmed Active Ingredients and Mechanisms of Change in Motivational Interviewing for Medication Adherence. A Mixed Methods Study of Patient-Therapist Interaction in Patients With Schizophrenia
title_sort active ingredients and mechanisms of change in motivational interviewing for medication adherence. a mixed methods study of patient-therapist interaction in patients with schizophrenia
publisher Frontiers Media S.A.
series Frontiers in Psychiatry
issn 1664-0640
publishDate 2020-03-01
description BackgroundTrials studying Motivational Interviewing (MI) to improve medication adherence in patients with schizophrenia showed mixed results. Moreover, it is unknown which active MI-ingredients are associated with mechanisms of change in patients with schizophrenia. To enhance the effect of MI for patients with schizophrenia, we studied MI's active ingredients and its working mechanisms.MethodsFirst, based on MI literature, we developed a model of potential active ingredients and mechanisms of change of MI in patients with schizophrenia. We used this model in a qualitative multiple case study to analyze the application of the active ingredients and the occurrence of mechanisms of change. We studied the cases of fourteen patients with schizophrenia who participated in a study on the effect of MI on medication adherence. Second, we used the Generalized Sequential Querier (GSEQ 5.1) to perform a sequential analysis of the MI-conversations aiming to assess the transitional probabilities between therapist use of MI-techniques and subsequent patient reactions in terms of change talk and sustain talk.ResultsWe found the therapist factor “a trusting relationship and empathy” important to enable sufficient depth in the conversation to allow for the opportunity of triggering mechanisms of change. The most important conversational techniques we observed that shape the hypothesized active ingredients are reflections and questions addressing medication adherent behavior or intentions, which approximately 70% of the time was followed by “patient change talk”. Surprisingly, sequential MI-consistent therapist behavior like “affirmation” and “emphasizing control” was only about 6% of the time followed by patient change talk. If the active ingredients were embedded in more comprehensive MI-strategies they had more impact on the mechanisms of change.ConclusionsMechanisms of change mostly occurred after an interaction of active ingredients contributed by both therapist and patient. Our model of active ingredients and mechanisms of change enabled us to see “MI at work” in the MI-sessions under study, and this model may help practitioners to shape their MI-strategies to a potentially more effective MI.
topic motivational interviewing
schizophrenia
medication adherence
active ingredients
mechanisms of change
url https://www.frontiersin.org/article/10.3389/fpsyt.2020.00078/full
work_keys_str_mv AT josdobber activeingredientsandmechanismsofchangeinmotivationalinterviewingformedicationadherenceamixedmethodsstudyofpatienttherapistinteractioninpatientswithschizophrenia
AT corinelatour activeingredientsandmechanismsofchangeinmotivationalinterviewingformedicationadherenceamixedmethodsstudyofpatienttherapistinteractioninpatientswithschizophrenia
AT bernovanmeijel activeingredientsandmechanismsofchangeinmotivationalinterviewingformedicationadherenceamixedmethodsstudyofpatienttherapistinteractioninpatientswithschizophrenia
AT bernovanmeijel activeingredientsandmechanismsofchangeinmotivationalinterviewingformedicationadherenceamixedmethodsstudyofpatienttherapistinteractioninpatientswithschizophrenia
AT bernovanmeijel activeingredientsandmechanismsofchangeinmotivationalinterviewingformedicationadherenceamixedmethodsstudyofpatienttherapistinteractioninpatientswithschizophrenia
AT gerbenterriet activeingredientsandmechanismsofchangeinmotivationalinterviewingformedicationadherenceamixedmethodsstudyofpatienttherapistinteractioninpatientswithschizophrenia
AT emilebarkhof activeingredientsandmechanismsofchangeinmotivationalinterviewingformedicationadherenceamixedmethodsstudyofpatienttherapistinteractioninpatientswithschizophrenia
AT ronpeters activeingredientsandmechanismsofchangeinmotivationalinterviewingformedicationadherenceamixedmethodsstudyofpatienttherapistinteractioninpatientswithschizophrenia
AT wilmascholteopreimer activeingredientsandmechanismsofchangeinmotivationalinterviewingformedicationadherenceamixedmethodsstudyofpatienttherapistinteractioninpatientswithschizophrenia
AT wilmascholteopreimer activeingredientsandmechanismsofchangeinmotivationalinterviewingformedicationadherenceamixedmethodsstudyofpatienttherapistinteractioninpatientswithschizophrenia
AT lieuwedehaan activeingredientsandmechanismsofchangeinmotivationalinterviewingformedicationadherenceamixedmethodsstudyofpatienttherapistinteractioninpatientswithschizophrenia
_version_ 1724928721082646528